Potential risks include inadequate disease management, unpredictable side effects and interactions with other medications. Dont be fooled by social media Its easy to get caught up in what youre seeing and hearing online, but if it seems too good to be true it probably is
The exact proportion varies by medication, person, study design and measurement method
These trials demonstrated its efficacy and safety in Type 2 diabetes with or without other anti-diabetic agents [42, 44,45,46,47]
[DOI] [PMC free article] [PubMed] [Google Scholar] [16].Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Torne CW, Ryan DH, Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, N Engl J Med (2023)
*We collect cookies for the functioning of our website and to give you the best experience
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial